Group Versus Internet-based Cognitive Behavior Therapy for Procrastination

Sponsor
Stockholm University (Other)
Overall Status
Completed
CT.gov ID
NCT02112383
Collaborator
Karolinska Institutet (Other)
90
1
2
25
3.6

Study Details

Study Description

Brief Summary

Procrastination is defined as a voluntarily delay of an intended course of action despite expecting to be worse-off for the delay, and is considered a persistent behavior pattern that can result in major psychological suffering. About one-fifth of the adult population and half of the student population are presumed having substantial difficulties due to recurrent procrastination in their everyday life. However, chronic and severe procrastinators seldom receive adequate care due to preconceptions and the lack of understanding regarding procrastination and the treatment interventions that are assumed beneficial. Cognitive behavior therapy is often deemed treatment of choice, although the evidence supporting its use is scarce, and only one randomized controlled trial has been performed. The primary aim of the current study is therefore to test the efficacy of cognitive behavior therapy delivered as either a group intervention or via the Internet. Participants will consist of students recruited through the Student Health Centre at Karolinska Institutet. A randomized controlled trial with a sample size of 100 participants divided into two conditions will be employed; a ten week Internet-based cognitive behavior therapy intervention, and an eight week group intervention based on cognitive behavior therapy. The current study is believed to result in two important findings. First, different interventions inherent in cognitive behavior therapy are assumed to be helpful for people suffering from problems caused by procrastination. Second, both a group intervention and an Internet-based cognitive behavior therapy intervention are presumed suitable for administering treatment for procrastination, which is considered highly important as the availability of adequate care is limited, particularly among students. The current study will increase the knowledge regarding the efficacy of different treatments of procrastination, as well as enhance the overall comprehension of the difficulties related to dilatory behavior.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive behavior group therapy
  • Behavioral: Internet-based cognitive behavior therapy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Group Versus Internet-based Cognitive Behavior Therapy for Procrastination
Actual Study Start Date :
Sep 1, 2014
Actual Primary Completion Date :
Oct 1, 2016
Actual Study Completion Date :
Oct 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Internet-based cognitive behavior therapy

Behavioral: Internet-based cognitive behavior therapy
For participants in the Internet-based condition, the modules from a self-help treatment for procrastination will be distributed weekly during the treatment period, with one module given each week, i.e., ten weeks. In comparison to the group condition, participants will not receive a therapist contact or attend any sessions. In addition, the participants are expected to complete both the reading material and the assignments that are included in each module.

Experimental: Cognitive behavior group therapy

Behavioral: Cognitive behavior group therapy
For participants in the group intervention condition, the modules from a self-help treatment for procrastination will be delivered at four consecutive three-hour sessions at the Student Health Centre at Karolinska Institutet, with approximately two modules given at each session. The sessions will be spaced two weeks apart, during which participants are instructed to complete assignments related to the modules that were in focus of the previous session, e.g., goal-setting, time management, and behavioral experiments, which they are advised to present and discuss with the other participants.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline on the Pure Procrastination Scale (PPS) [0 weeks and 8 or 10 weeks]

    The PPS features twelve items measuring the prevalence of procrastination.

  2. Change from baseline on the Pure Procrastination Scale (PPS) [0 weeks and 24 weeks]

    The PPS features twelve items measuring the prevalence of procrastination.

  3. Change from baseline on the Procrastination Assessment Scale for Students (PASS) [0 weeks and 8 or 10 weeks]

    The PASS features three items measuring difficulties of procrastination within six different domains of study related activities.

  4. Change from baseline on the Procrastination Assessment Scale for Students (PASS) [0 weeks and 24 weeks]

    The PASS features three items measuring difficulties of procrastination within six different domains of study related activities.

Secondary Outcome Measures

  1. Change from baseline on the Montgomery-Åsberg Depression Rating Scale (MADRS-S) [0 weeks and 8 or 10 weeks]

    The MADRS-S is a self-report version of MADRS and features nine items measuring changes in mood, anxiety, sleeping patterns, appetite, concentration, initiative, emotional engagement, pessimism and attitude towards life.

  2. Change from baseline on the Montgomery-Åsberg Depression Rating Scale (MADRS-S) [0 weeks and 24 weeks]

    The MADRS-S is a self-report version of MADRS and features nine items measuring changes in mood, anxiety, sleeping patterns, appetite, concentration, initiative, emotional engagement, pessimism and attitude towards life.

  3. Change from baseline on the Generalized Anxiety Disorder Assessment (GAD-7) [0 weeks and 8 or 10 weeks]

    The GAD-7 features seven items for assessing anxiety and screening for generalized anxiety disorder.

  4. Change from baseline on the Generalized Anxiety Disorder Assessment (GAD-7) [0 weeks and 24 weeks]

    The GAD-7 features seven items for assessing anxiety and screening for generalized anxiety disorder.

  5. Change in baseline on the Symptoms Checklist 90 (SCL-90) [0 weeks and 8 or 10 weeks]

    SCL-90 features 90 items evaluating the participant's physical health and mental well-being, and consists of three global domains as well as nine subdomains.

  6. Change in baseline on the Symptoms Checklist 90 (SCL-90) [0 weeks and 24 weeks]

    SCL-90 features 90 items evaluating the participant's physical health and mental well-being, and consists of three global domains as well as nine subdomains.

Other Outcome Measures

  1. Open-ended questions concerning adverse events [4/5 weeks, 8/10 weeks, six-month follow-up]

    The occurrence and characteristics of possible negative effects of treatment will be examined using open-ended questions, i.e., "did you experience any negative effects during treatment", including rating scales assessing the degree to which the adverse event has affected the participant.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Fluent in Swedish

  • Computer with Internet access and a working email

  • Registered as students at one of the affiliated universities of the Student Health Centre at Karolinska Institutet

  • Primary difficulties related to chronic and severe procrastination

Exclusion Criteria:
  • Severe depression (30 points or more on MADRS-S)

  • Acute conditions in need of treatment; suicidal ideation, neuropsychiatric conditions (ADHD, ADD), misuse of alcohol or drugs, bipolar disorder, schizophrenia, and psychosis

  • Ongoing psychotherapy

  • Ongoing psychotropic medication (unless dose is stable three months prior the entering treatment)

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Student Health Centre at Karolinska Institutet. Huddinge Sweden 141 52

Sponsors and Collaborators

  • Stockholm University
  • Karolinska Institutet

Investigators

  • Principal Investigator: Per Carlbring, PhD, Stockholm University
  • Study Director: David Forsström, MSc, Stockholm University
  • Study Director: Alexander Rozental, MSc, Stockholm University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Per Carlbring, Professor, Stockholm University
ClinicalTrials.gov Identifier:
NCT02112383
Other Study ID Numbers:
  • SU-KI-STUDENT
First Posted:
Apr 11, 2014
Last Update Posted:
Mar 13, 2018
Last Verified:
Mar 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Per Carlbring, Professor, Stockholm University

Study Results

No Results Posted as of Mar 13, 2018